Details of the Drug Reposition

General Information of This Drug (ID: DMNRYPF)

Drug Name
Cixutumumab   DMNRYPF
Synonyms LY3012217
Drug Type
Monoclonal antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Liver cancer DISDE4BI 2C12 Phase 2 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 2 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT01232452) A Study in Non-Small Cell Lung Cancer. U.S. National Institutes of Health.